한글목차

세계 개 백신 시장의 미래는 동물병원 및 클리닉과 반려동물 보호자 시장에 기회가 있을 것으로 보입니다. 세계 개 백신 시장은 2025-2031년 5.7%의 연평균 복합 성장률(CAGR)로 2031년까지 약 49억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 반려견 사육 수 증가, 반려견의 예방적 헬스케어의 이점에 대한 보호자의 인식 증가, 예방접종에 대한 정부 규제 등입니다.

• Lucintel의 예측에 따르면 유형별로는 반려견의 감염성 질환 발병률 증가, 다른 백신과 비교했을 때 편의성과 효과로 인해 약독성 생백신이 계속해서 가장 큰 부문을 차지할 것으로 예상됩니다.
• 최종사용자 카테고리에서는 동물병원 및 클리닉이 예측 기간 중 높은 성장세를 보일 것으로 예상됩니다.
• 지역별로 보면 북미는 심각한 질병으로부터 개를 보호하고개 물림으로부터 인명을 보호하기 위해 백신 접종에 대한 정부 규제가 엄격하므로 가장 규모가 큰 지역으로 남을 것으로 보입니다.

개 백신 시장의 전략적 성장 기회

개 백신 시장은 기술 발전, 반려동물 사육률 증가, 예방접종 캠페인 확대 등으로 인해 주요 용도에서 몇 가지 전략적 성장 기회를 제공합니다.

• 신흥 시장 확대: 개 백신 접종 프로그램을 신흥 시장으로 확대하는 것은 큰 성장 잠재력을 가지고 있습니다. 이를 통해 더 나은 접근성과 경제성을 확보하고, 더 많은 시장 점유율을 확보하며, 반려견의 질병 부담을 줄일 수 있습니다.
• 다가백신 개발: 다양한 질병을 대상으로 하는 다가백신에 대한 투자는 백신 접종 과정을 간소화하고 백신 접종 순응도를 향상시킬 수 있습니다.
• 더 나은 백신 제제: 부작용이 적고 면역력이 더 오래 지속되는 새로운 백신 제제의 개발은 이점이 있습니다. 이러한 발전을 활용하면 반려견의 예방접종 수용과 활용을 촉진할 수 있습니다.
• 디지털 건강 플랫폼 통합: 디지털 건강 플랫폼을 백신 배포 및 추적에 통합하여 백신 접종률을 높이고 반려동물의 전반적인 건강을 향상시킬 수 있습니다. 이러한 플랫폼을 통해 예약 스케줄링과 재고 관리를 개선할 수 있습니다.
• 혁신적인 백신 제공 방법: 경구용 백신과 같은 혁신적인 백신 투여 방법을 개발하여 반려동물 보호자가 쉽게 백신을 접종할 수 있도록 합니다. 이는 백신 접종률 증가로 인한 성장 기회를 의미합니다.

이러한 기회는개 백신 산업과 관련된 공중보건 분야의 접근성 개선과 백신 기술 발전에 변화를 가져오고 있습니다.

개 백신 시장 성장 촉진요인 및 과제

기술 발전, 경제적 요인, 규제에 대한 고려는 개 백신 시장에 영향을 미치는 촉진요인 및 과제 중 하나입니다. 따라서 시장 상황을 헤쳐나가기 위해서는 이러한 요소들을 이해하는 것이 필수적입니다.

개 백신 시장을 촉진하는 요인은 다음과 같습니다. :

• 반려동물 소유자 증가: 전 세계 반려동물 사육 수 증가는 개 백신 수요를 지원하는 큰 힘이 되고 있습니다. 반려동물을 키우는 가정이 늘어남에 따라 백신 접종을 포함한 예방 의료가 필요해지면서 시장 성장을 가속하고 있습니다.
• 기술 발전: 다가 백신, 경구용 백신 등 백신 기술의 발전은 백신 수요를 더욱 증가시키고 있습니다. 이러한 발전으로 백신은 더욱 효과적이고 편리해져 보급률을 높일 수 있게 되었습니다.
• 정부 캠페인: 특히 신흥 국가에서는 정부 주도의 백신 접종 캠페인이 개 백신 판매를 촉진하고 있습니다. 이러한 캠페인은 광견병과 같은 질병 관리에 도움이 되어 시장 확대에 기여하고 있습니다.
• 수의학 인프라 확대: 특히 신흥 시장에서는 수의학 서비스 및 시설의 확대로 개 백신에 대한 접근성이 향상되고 있습니다. 수의학 인프라의 개선으로 더 많은 반려동물이 적시에 예방접종을 받을 수 있게 되어 전체 시장 성장을 촉진하고 있습니다.

개 백신 시장이 해결해야 할 과제는 다음과 같습니다. :

• 경제적 제약: 경제적 제약: 백신의 제조 비용과 가격 등 경제적 문제는 이 시장 부문에 변동성을 가져올 수 있습니다. 확장하면서도 경쟁력을 유지하기 위해서는 비용과 품질의 균형을 맞추는 것이 필수적입니다.
• 규제적 장애물: 백신 승인 및 안전성에 대한 엄격한 규제를 준수하는 것은 어려운 과제입니다. 이러한 요건을 충족하는 것은 시장 진입과 제품 개발에 필수적이지만, 이로 인해 프로세스가 지연되고 비용이 증가할 수 있습니다.
• 백신 접종에 대한 주인의 주저함: 백신 접종에 대한 주저함이 이 산업의 성장을 저해하는 요인으로 작용하고 있습니다. 백신의 안전성과 효능에 대한 우려를 해결하면 예방접종률을 크게 향상시키고 전체 시장을 확대할 수 있습니다.

이러한 시장 성장 촉진요인 및 과제들이 제품 개발, 시장 개발, 규제 준수 등을 규정하며 개 백신 시장을 형성하고 있습니다.

목차

제1장 개요

제2장 세계의 개 백신 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계의 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 개 백신 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 개 백신 시장 : 유형별
  • 약독생백신
  • 결합 백신
  • 불활화 백신
  • 서브유닛 백신
  • 톡소이드 백신
  • DNA 백신
  • 재조합 백신
• 세계의 개 백신 시장 : 연령별
  • 6개월 미만
  • 6개월 이상
• 세계의 개 백신 시장 : 최종 용도별
  • 동물병원·클리닉
  • 애완동물 소유주
  • 기타

제4장 지역별 시장 동향과 예측 분석(2019-2031년)

• 세계의 개 백신 시장 : 지역별
• 북미의 개 백신 시장
• 유럽의 개 백신 시장
• 아시아태평양의 개 백신 시장
• 기타 지역의 개 백신 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 개 백신 시장의 성장 기회 : 유형별
  • 세계의 개 백신 시장의 성장 기회 : 연령별
  • 세계의 개 백신 시장의 성장 기회 : 최종 용도별
  • 세계의 개 백신 시장의 성장 기회 : 지역별
• 세계의 개 백신 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 개 백신 시장의 생산능력 확대
  • 세계의 개 백신 시장에서의 기업인수합병(M&A), 합병사업
  • 인증과 라이선싱

제7장 주요 기업의 개요

• Bayer
• Vetquinol
• Boehringer Ingelhiem
• Ceva
• Eli Lilly
• Heska
• Merck

영문목차

The future of the global dog vaccine market looks promising with opportunities in the veterinary hospital & clinic and pet owner markets. The global dog vaccine market is expected to reach an estimated $4.9 billion by 2031 with a CAGR of 5.7% from 2025 to 2031. The major drivers for this market are the increasing adoption of pet dogs, growing awareness among pet owners about the benefits of preventive healthcare for their dogs, and government regulations for vaccinations.

• Lucintel forecasts that, within the type category, attenuated live will remain the largest segment due to the rising incidence of infectious diseases among dogs, as well as the convenience and effectiveness of this vaccine compared to others.
• Within the end-use category, veterinary hospitals & clinics are expected to witness higher growth over the forecast period.
• In terms of regions, North America will remain the largest region due to strict government regulations regarding vaccination to protect dogs from serious diseases, as well as to protect human life from dog biting.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Dog Vaccine Market

Dog vaccines are significantly changing due to evolving consumer tastes, technological developments, and increased awareness of dog health. The demand for innovative and efficient vaccines is rising as the incidence of pet ownership continues to increase globally. Several trends will shape the market and influence the development, distribution, and administration of vaccines.

• Manifold Vaccines: The trend toward manifold vaccines that protect dogs from numerous diseases with just one injection is growing. This simplifies the vaccination process, enhances compliance, and reduces stress for both dogs and owners.
• Digital Health Platforms: The integration of digital health platforms has revolutionized vaccine distribution and tracking. These platforms improve inventory management, appointment scheduling, and follow-up reminders, thereby increasing vaccination rates and overall pet health.
• Global Expansion of Pet Ownership: The rise in pet ownership in emerging markets is driving increased demand for dog vaccines. More households are acquiring pets in nations such as China and India, resulting in an expanding market for vaccines and increased production and distribution.
• Focus on Vaccine Safety and Efficacy: Attention is rising regarding the safety and effectiveness of dog vaccines. More stringent regulations have been established by regulatory bodies to ensure that these products are not only safe for pets but also effective in preventing diseases.
• Innovative Vaccine Delivery Methods: Oral vaccines and other novel delivery techniques are gaining popularity. These methods make it easier for pet owners to vaccinate their animals, thereby reducing the anxiety often associated with injectable vaccines.

These trends are reshaping the dog vaccine market by enhancing vaccine technology, expanding access, and improving overall pet health.

Recent Developments in the Dog Vaccine Market

The dog vaccine market is experiencing several key developments that spur growth and innovation in canine healthcare.

• Development of Multi-Valent Vaccines: Companies are introducing multi-valent vaccines that prevent various diseases with one shot. This makes the vaccination process easier and achieves higher compliance among pet owners.
• Expansion of Vaccine Access in Emerging Markets: Ongoing efforts aim to expand access to dog vaccines in emerging markets. This expansion is fueled by increased pet ownership and government initiatives aimed at controlling diseases like rabies.
• Advancements in Vaccine Formulations: Recent advances in vaccine formulations have resulted in more effective vaccines with fewer side effects. These improvements enhance vaccine performance and increase acceptance among pet owners.
• Integration of Digital Health Platforms: Vaccination rates are improving through the adoption of digital health platforms for vaccine distribution and tracking. These platforms facilitate better inventory management, appointment scheduling, and follow-up reminders.
• Innovation in Vaccine Delivery Methods: New vaccine delivery methods, such as oral vaccines, are being developed to simplify the process of vaccinating dogs. These innovations will increase vaccine uptake and improve overall pet health.

By enhancing vaccine technology, increasing access, and improving overall pet health, these developments propel the dog vaccine market forward.

Strategic Growth Opportunities for Dog Vaccine Market

The dog vaccine market presents several strategic opportunities for growth across major applications due to technological improvements, rising pet ownership, and expanding immunization campaigns.

• Emerging Markets Expansion: There is significant potential for growth in extending dog vaccination programs to emerging markets. By doing so, better access and affordability can be achieved, capturing more market share and reducing the canine disease burden.
• Development of Multi-Valent Vaccines: Investing in multi-valent vaccines that target various diseases can simplify the vaccination process and boost adherence, offering additional revenue opportunities by increasing attractiveness to buyers.
• Better Vaccine Formulations: The creation of new vaccine formulations that are less likely to cause side effects while providing longer immunity has its advantages. Utilizing these advancements can encourage the acceptance and use of dog vaccinations.
• Digital Health Platform Integration: Integrating digital health platforms into vaccine distribution and tracking leads to improved vaccination rates and enhances pets' overall health. Improved appointment scheduling and inventory management can be facilitated through these platforms.
• Innovative Methods of Vaccine Delivery: Developing innovative methods of vaccine delivery, such as oral vaccines, makes vaccination easier for owners. This represents an opportunity for growth through increased vaccine uptake.

These opportunities are driving changes in access improvements and advancing vaccine technology within the public health sector related to the dog vaccine industry.

Dog Vaccine Market Driver and Challenges

Technological advancements, economic factors, and regulatory considerations are among the drivers and challenges influencing the dog vaccine market. Therefore, it is essential to understand these elements to navigate the market landscape.

The factors driving the dog vaccine market include:

• Increased Number of Pet Owners: The global rise in pet ownership is a significant force behind the demand for dog vaccines. As more families keep pets, they require preventive care, including vaccinations, fostering market growth.
• Technological Advances: Improvements in vaccine technology, such as multi-valent vaccines and oral administration options, have further increased demand. These developments make vaccines more effective and convenient, ensuring higher adoption rates.
• Government Campaigns: Government-led vaccination initiatives, particularly in emerging economies, have boosted dog vaccine sales. These campaigns help manage diseases like rabies, contributing to market expansion.
• Expanding Veterinary Infrastructure: The expansion of veterinary services and facilities, particularly in emerging markets, is facilitating greater access to dog vaccines. Improved veterinary infrastructure ensures that more pets receive timely vaccinations, supporting overall market growth.

Challenges in the dog vaccine market include:

• Financial Constraints: Economic issues, such as the cost of manufacturing vaccines and their affordability, can cause fluctuations within this market segment. It is imperative to balance cost and quality to remain competitive while expanding.
• Regulatory Hurdles: Compliance with strict regulations regarding vaccine approval and safety can be challenging. Meeting these requirements is essential for gaining access to target markets and developing products, which can delay processes and increase costs.
• Reluctance Toward Vaccination: Pet owners' hesitancy toward vaccinations poses a barrier to growth in this industry. Addressing concerns about vaccine safety and effectiveness can significantly raise immunization coverage and expand the overall market.

These drivers and challenges define product development, market growth, and regulatory compliance, thereby shaping the dog vaccine market.

List of Dog Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies dog vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the dog vaccine companies profiled in this report include-

• Bayer
• Vetquinol
• Boehringer Ingelhiem
• Ceva
• Eli Lilly
• Heska
• Merck

Dog Vaccine by Segment

The study includes a forecast for the global dog vaccine market by type, age, end use, and region.

Dog Vaccine Market by Type [Analysis by Value from 2019 to 2031]:

• Attenuated Live Vaccines
• Conjugate Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• Toxoid Vaccines
• DNA Vaccines
• Recombinant Vaccine

Dog Vaccine Market by Age [Analysis by Value from 2019 to 2031]:

• Below 6 Months
• Above 6 Months

Dog Vaccine Market by End Use [Analysis by Value from 2019 to 2031]:

• Veterinary Hospitals & Clinics
• Pet Owners
• Others

Dog Vaccine Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Dog Vaccine Market

Improvements in pet ownership, growing awareness of dog health, and technological advancements are contributing to significant progress in the dog vaccine sector. Vaccine formulations, distribution channels, and government initiatives guiding dog vaccination rates and general pet healthcare are undergoing notable changes in key markets such as the US, China, Germany, India, and Japan.

• United States: There is increased demand for multi-valent dog vaccines that protect against multiple diseases, reducing the number of injections required. Additionally, digital platforms are being adopted to enhance vaccine distribution and monitoring, thus improving overall vaccination compliance rates and coverage.
• China: China is experiencing rapid growth in the dog vaccine market due to its expanding middle class, resulting in a higher number of pets owned per household. The government has launched various campaigns aimed at controlling rabies and other diseases, while local manufacturers are diversifying their product range to meet rising demands.
• Germany: Research activities targeting new canine diseases are prevalent in Germany. The country has also tightened quality control requirements to ensure that all newly developed vaccines meet high standards before being sold.
• India: The Indian dog vaccine market is growing due to the introduction of low-cost vaccines, particularly for rural communities. Government initiatives are facilitating widespread rabies vaccinations, while private sector players are entering vaccine manufacturing and distribution to meet current needs.
• Japan: Japan has advanced in creating innovative vaccine forms, including oral vaccines, which simplify the vaccination process for pet owners. Furthermore, the nation has improved its regulatory framework regarding safe and effective vaccine development, supporting a rise in preventive pet healthcare.

Features of the Global Dog Vaccine Market

Market Size Estimates: Dog vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Dog vaccine market size by type, age, end use, and region in terms of value ($B).

Regional Analysis: Dog vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, ages, end uses, and regions for the dog vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the dog vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the dog vaccine market by type (attenuated live vaccines, conjugate vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines, and recombinant vaccine), age (below 6 months and above 6 months), end use (veterinary hospitals & clinics, pet owners, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Dog Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Dog Vaccine Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Dog Vaccine Market by Type
  • 3.3.1: Attenuated Live Vaccines
  • 3.3.2: Conjugate Vaccines
  • 3.3.3: Inactivated Vaccines
  • 3.3.4: Subunit Vaccines
  • 3.3.5: Toxoid Vaccines
  • 3.3.6: DNA Vaccines
  • 3.3.7: Recombinant Vaccine
• 3.4: Global Dog Vaccine Market by Age
  • 3.4.1: Below 6 months
  • 3.4.2: Above 6 months
• 3.5: Global Dog Vaccine Market by End Use
  • 3.5.1: Veterinary Hospitals & Clinics
  • 3.5.2: Pet Owners
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Dog Vaccine Market by Region
• 4.2: North American Dog Vaccine Market
  • 4.2.1: North American Market by Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccine
  • 4.2.2: North American Market by End Use: Veterinary Hospitals & Clinics, Pet Owners, and Others
• 4.3: European Dog Vaccine Market
  • 4.3.1: European Market by Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccine
  • 4.3.2: European Market by End Use: Veterinary Hospitals & Clinics, Pet Owners, and Others
• 4.4: APAC Dog Vaccine Market
  • 4.4.1: APAC Market by Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccine
  • 4.4.2: APAC Market by End Use: Veterinary Hospitals & Clinics, Pet Owners, and Others
• 4.5: ROW Dog Vaccine Market
  • 4.5.1: ROW Market by Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccine
  • 4.5.2: ROW Market by End Use: Veterinary Hospitals & Clinics, Pet Owners, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Dog Vaccine Market by Type
  • 6.1.2: Growth Opportunities for the Global Dog Vaccine Market by Age
  • 6.1.3: Growth Opportunities for the Global Dog Vaccine Market by End Use
  • 6.1.4: Growth Opportunities for the Global Dog Vaccine Market by Region
• 6.2: Emerging Trends in the Global Dog Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Dog Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Dog Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Bayer
• 7.2: Vetquinol
• 7.3: Boehringer Ingelhiem
• 7.4: Ceva
• 7.5: Eli Lilly
• 7.6: Heska
• 7.7: Merck